Commonalities in cortical neurodegeneration between type 2 diabetes and Alzheimer's disease
Journal of Alzheimer’s Disease · 2025
DOI: 10.1177/13872877251365671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Mahboubeh Motaghi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Médecine, Université Laval, Québec, QC, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Cognitive Dysfunction. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS.
Themen: Diabetes mellitus, Demenz
Abstract (Originalsprache)
Background
Type 2 diabetes (T2D) is a prevalent metabolic condition associated with increased risk of cognitive decline and dementia, including Alzheimer's disease (AD). While both T2D and AD are linked to neurodegeneration, the extent to which their patterns of brain atrophy overlap remain unclear.
Objective
To assess the similarities and differences in cortical atrophy patterns among individuals with controlled and uncontrolled T2D, mild cognitive impairment (MCI), and AD.
Methods
Structural magnetic resonance imaging data from the UK Biobank (UKBB) and the Alzheimer's Disease Neuroimaging Initiative (ADNI) were analyzed. Participants aged 55 and older were selected. Linear regression models were applied to generate cortical thickness maps for each group, controlling for age and sex. Group comparisons were conducted using permutation-based tests accounting for spatial autocorrelation.
Results
The study included 175 individuals with T2D (86 uncontrolled, 89 controlled) and 127 healthy controls without diabetes (HC) from UKBB, 334 individuals with MCI, 119 with AD and 315 cognitively healthy (CH) from ADNI. Uncontrolled T2D was associated with significant cortical atrophy in specific brain regions, with partial overlap in neurodegeneration patterns observed in MCI and AD. However, correlations between the cortical thinning patterns were weak and non-significant, suggesting distinct trajectories. Controlled T2D showed no significant cortical thinning, supporting the potential neuroprotective effects of glycemic control.
Conclusions
Uncontrolled T2D is linked to region-specific cortical atrophy that partially overlaps with MCI and AD but follows an independent neurodegenerative trajectory. Effective diabetes management may help preserve brain structure and reduce dementia risk, highlighting the importance of early metabolic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculté de Médecine, Université Laval, Québec, QC, Canada.
- MEDICS Laboratory, Quebec Heart and Lung Institute (IUCPQ), Québec, QC, Canada.
- Département de Radiologie et Médecine Nucléaire, Université Laval, Québec, QC, Canada.
Förderung
- NIA NIH HHS
Zitieren
APA
Motaghi, M., Potvin, O., Duchesne, S., & Alzheimer's Disease Neuroimaging Initiative (2025). Commonalities in cortical neurodegeneration between type 2 diabetes and Alzheimer's disease. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251365671
Vancouver
Motaghi M, Potvin O, Duchesne S, Alzheimer's Disease Neuroimaging Initiative. Commonalities in cortical neurodegeneration between type 2 diabetes and Alzheimer's disease. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251365671
BibTeX
@article{Motaghi2025,
author = {Motaghi, Mahboubeh and Potvin, Olivier and Duchesne, Simon and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Commonalities in cortical neurodegeneration between type 2 diabetes and Alzheimer's disease},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
doi = {10.1177/13872877251365671}
}
EUVIMED